Blog
CRISPR/Cas9 deletions induce adverse on-target genomic effects
In a recent study, a team of researchers used a
In a recent study, a team of researchers used a
With a $17 million grant, UCSF Benioff Children’s Hospital in
The FDA has granted accelerated designation to PRGN-3006 for the
Mucopolysaccharidosis I is caused by mutations in the gene for
In the process of engineering CAR T cells, if the
Many people are excluded from CAR T cell-based treatments because
CAR T-cell therapy and antibody treatments are two types of
CARCIK-CD19, an investigational therapy developed by scientists in Italy, involves
The mammalian brain contains many specialized cells that develop from